Most not long ago, it has been recognized that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds to the big range of endogenous opioids. Compared with most opioid receptors,